Methylphenidate enhances or impairs the cognitive control of Pavlovian bias depending on working memory capacity
Figures
Experimental design and basic results.
(A) Study timeline. A battery of six tasks was performed in a fixed order on 2 days. The Pavlovian-to-instrumental transfer (PIT) task was always performed first to minimise interference between training and transfer. Average timings are indicated, with timings most relevant for the PIT task data presented here in purple. Tasks marked in black have been published/are in preparation elsewhere (Swart et al., 2017; Froböse et al., 2018; Cook et al., 2019; Rostami Kandroodi et al., 2021). Working memory (WM) was assessed with a listening span task prior to drug intake on day 2 of the study. Impulsivity was assessed with the Barratt Impulsiveness Scale (BIS-11), which participants filled out in the interval between the two testing sessions like the other Mood & Medical Symptom ratings (MMSR). (B–D) PIT task design and main task effects (averaged across drug conditions) for the three task phases. (B) Instrumental training. Design (upper panel): Participants had to choose whether to click (‘Go’) or not click (‘NoGo’) with the mouse inside the blue frame. Trials were grouped into Approach and Withdrawal blocks. In the Approach context, a Go response resulted in ‘collecting’ the mushroom, while NoGo meant not collecting it. In the Withdrawal context, a Go would ‘discard’ the mushroom, while NoGo would keep it. Each mushroom only appeared in either Approach or Withdrawal contexts. For each mushroom, one action (Go or NoGo) was correct and rewarded with 75% probability. The other action was punished with 75% probability. Participants were instructed that the outcomes received counted towards a bonus payment. Each block contained six unique mushrooms. Results (lower panel): mean ± standard error of the mean. Participants learnt to make the correct response for each of the required actions and Action Contexts. Note that for approach contexts, people initially displayed a Go bias, which led to above chance performance for Go-Approach cues and below-chance performance for NoGo-Approach cues. However, at the end of training, all cue/context combinations reached the same plateau, which approximately probability-matched the reward contingency. (C) Pavlovian conditioning. Design (upper panel): In the conditioning trials, five fractals were presented repeatedly, followed deterministically by monetary outcomes of five value levels: high (100) or low (10) reward, nothing (0), low (–10), or high (–100) punishment. Intermixed with the conditioning trials, 18 query trials were presented, where participants had to select the most rewarding of a random selection of two of the stimuli. The line plot shows average probability of selecting the higher conditioned stimulus (CS) across participants and drug sessions, as a function of valence level difference. Participants rapidly learned to select the better CS. Prior to and post conditioning, subjects were asked to rate how much they liked each fractal on a visual analogue scale (VAS). Results (lower panel): VAS significantly increased for appetitive CSs, while they were reduced for aversive stimuli. Circles represent individual subjects. (D) PIT. Design (upper panel): Participants performed the instrumental training task in nominal extinction (they were instructed that their actions still counted towards their payment). On every trial, one of the Pavlovian CSs tiled the background. Results (lower panel): Proportion of Go responses independent of required response. In the Approach context (green), presence of a positive Pavlovian CS increased Go (active approach), while a negative Pavlovian CS reduced Go (relative to a neutral CS). In contrast, in the Withdrawal context, the negative Pavlovian CS enhanced Go (active withdrawal), while the positive CS reduced Go. For panels C and D, results are collapsed within valence (i.e. high and low reward CS and high and low punishment CS were averaged). See Figure 1—figure supplement 1 for each of the valence levels separately.
Basic VAS and PIT results for five levels of conditioned stimulus reinforcement.
(A) Pavlovian conditioning effects and Pavlovian-to-instrumental transfer (PIT) effects as a function of all five levels of conditioned stimulus (CS) reinforcement. Liking ratings scale linearly with the levels of reinforcement, i.e., the CS associated with a large reward was liked more than the CS associated with a small reward, and vice versa for punishments. (B) In contrast, PIT effects are a function of the sign (aversive, neutral, appetitive), but not the magnitude (10 vs. 100), of the CS valence. In other words, PIT effects were equally strong for large and small reinforcers of each valence.
Effects of methylphenidate (MPH) on Pavlovian-instrumental transfer (PIT).
(A) Individual data points plus associated density distributions for the difference in likelihood of a Go response under MPH minus placebo (PLA). Data are plotted as a function of Action and Valence Context. There was no main effect of MPH. (B, C) MPH affects action-specific PIT (i.e. the Action Context-specific impact of Pavlovian valence on invigoration) as a function of baseline working memory capacity. Plots show the regression line and 95% confidence intervals, and in B also show individual data points. (B) Effects of MPH on action-specific PIT (Action Context × Valence Context), for each Pavlovian Valence Context (Action Context × Valence Context × Drug × Listening Span: X2=9.5, p=0.002) (see figure supplement for each of the five valence levels separately) (C) Breaking down the four-way interaction demonstrates the full reversal of the effect of drug on action-specific PIT as a function of working memory (listening span) performance. In short, under placebo, action-specific PIT is present in people with low, but not high, working memory span, while under MPH action-specific PIT is present in people with high, but not low, working memory span. See Figure 2 - Figure supplement 1 for each of the valence levels separately.
Tables
Breaking down the 4-day interaction into component factors; PLA: placebo; MPH: methylphenidate; WM: working memory.
| X2 | p-Value | |
|---|---|---|
| Main four-way interaction | ||
| Action Context × Valence Context × Drug × WM span | 9.5 | 0.002 |
| Simple interaction: Valence Context | ||
| Appetitive: Action Context × Drug × WM span | 9.4 | 0.002 |
| Neutral: Action Context × Drug × WM span | 0.2 | 0.7 |
| Aversive: Action Context × Drug × WM span | 5.0 | 0.026 |
| Simple interaction: Action Context | ||
| Approach: Valence Context × Drug × WM span | 1.2 | 0.3 |
| Withdrawal: Valence Context × Drug × WM span | 5.9 | 0.015 |
| Simple interaction: Drug | ||
| MPH: Action Context × Valence Context × WM span | 0.99 | 0.3 |
| PLA: Action Context × Valence Context × WM span | 2.1 | 0.15 |
Demographics, experimental information and results of neuropsychological assessments and self-report questionnaires at baseline.
| N=100 | Characteristic | Measure | Mean (std) | Min-max | Range* |
|---|---|---|---|---|---|
| Demographics | Age | Years | 21.6 (2.3) | 18–28 | – |
| Gender | Men/women | 50/50 | – | – | |
| Experimental information | Order | Placebo first/MPH first | 52/48 | – | – |
| Mean delay methylphenidate to task start | Minutes | 49.1 (2.1) | 40–61 | – | |
| Neuropsychological assessment | Verbal intelligence | NLV | 93.5 (7.7) | 75–114 | 55–145 |
| Working memory capacity | Listening span: total span | 4.8 (1.1) | 2.5–7 | 0–7 | |
| Digit span† Forward Backward | 16.8 (3.6) | 10–26 | 0–28 | ||
| 14.4 (3.1) | 8–23 | 0–28 | |||
| Self-report questionnaires | Impulsivity | BIS-11: total score | 62.0 (8.5) | 43–93 | 30–120 |
| Need for Cognition | NCS | 63.3 (10.5) | 38–82 | 18–90 | |
| Depressive symptoms | BDI | 3.6 (3.9) | 0–21 | 0–63 | |
| Behavioural activation | BAS: total score | 23.3 (4.0) | 15–34 | 13–52 | |
| Behavioural inhibition | BIS | 16.3 (3.6) | 7–23 | 7–28 | |
| Anxiety symptoms | STAI | 32.5 (6.9) | 23–55 | 20–80 | |
| Social support | MDSPSS: total | 70.5 (9.6) | 43–84 | 12–84 | |
| Social status | BSMSS: total | 48.0 (12.7) | 14.5–66 | 8–66 | |
| Social dominance | SADQ: social | 4.1 (0.9) | 2.1–5.9 | 1–7 | |
| Aggressive dominance | SADQ: aggressive | 2.6 (0.6) | 1.3–4.6 | 1–7 |
-
Demographic and background characteristics of participants included in the analysis. Questionnaires included the Beck Depression Inventory (BDI; Beck et al., 1996), Behavioral Inhibition Scale/Behavioral Activation Scale (BIS/BAS; Carver and White, 1994), Spielberger Trait Anxiety Inventory (STAI; Spielberger et al., 1983), Multidimensional Scale of Perceived Social Support (MDSPSS; Zimet et al., 1988), Social and Aggressive Dominance Questionnaire (SADQ; Kalma et al., 1993), and Barratt Simplified Measure of Social Status (BSMSS; Barratt, 2006).
-
*
Range reflects the possible range of scores on the questionnaires, whereas min-max and mean (std) reflect the participant data.
-
†
Average across two testing days. Digit span was completed prior to drug intake.